TITLE

Review: Haloperidol does not reduce agitation in dementia

AUTHOR(S)
Wilkinson, David
PUB. DATE
May 2002
SOURCE
ACP Journal Club;May/Jun2002, Vol. 136 Issue 3, p105
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Comments on a study which investigated the use of haloperidol for agitation in dementia. Effectiveness of haloperidol on patients with dementia; Side effects which may have confounded any reductions in psychotic symptoms.
ACCESSION #
8856106

 

Related Articles

  • Treating Dementia and Agitation. Small, Gary W. // JAMA: Journal of the American Medical Association;2/19/2014, Vol. 311 Issue 7, p677 

    The author comments on a study published within the issue on the safety and effectiveness of the selective serotonin reuptake inhibitor citalopram and a psychosocial intervention alternative drug treatment for dementia and agitation. He finds that the study authors failed to discuss when and how...

  • Update on neuropsychiatrie symptoms of dementia: Antipsychotic use. Kalapatapu, Raj K.; Schimming, Corbett // Geriatrics;May2009, Vol. 64 Issue 5, p10 

    The article provides an overview of data on the efficacy of atypical and conventional antipsychotics for the treatment of agitation. The efficacy of these drugs, such as olanzapine and haloperidol, for treatment of neuropsychotic symptoms of dementia is discussed in detail. A discussion of...

  • RESEARCH.  // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;7/23/2011, Vol. 343 Issue 7816, p191 

    No abstract available.

  • Quetiapine worsens cognitive decline in Alzheimer's disease.  // Reactions Weekly;2/26/2005, Issue 1040, p5 

    Discusses research being done on the efficacy of antipsychotic drugs quetiapine and rivastigmine in treating Alzheimer's disease, dementia and agitation. Reference to a study by C. Ballard, M. Margallo-Lana, E. Juszczak, S. Douglas, A. Swann et al, published in a 2005 issue of the "British...

  • Continuum of care: Stabilizing the acutely agitated patient. Bellnier, Terrance J. // American Journal of Health-System Pharmacy;9/1/2002 Supplement 5, Vol. 59, pS12 

    The safety and efficacy of i.m. ziprasidone and olanzapine for treating acute agitation in patients with factors to consider when evaluating the cost-effectiveness of these agents. Agitation is defined as excessive motor and verbal activity. Acute agitation has traditionally been treated with...

  • butyrophenone.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p333 

    An encyclopedia entry for the drug butyrophenone, which is used for treating psychoses, acute agitation and other disorders, is presented.

  • Agitation and Delirium at the End of Life. Breithart, William; Alici, Yesne // JAMA: Journal of the American Medical Association;12/24/2008, Vol. 300 Issue 24, p2898 

    A quiz concerning the clinical management of agitation and delirium at the end of life is presented.

  • Soothing sounds: reducing agitation with music therapy. Clare, Moira // British Journal of Healthcare Assistants;Apr2014, Vol. 8 Issue 4, p190 

    People with dementia may display agitated behaviours that staff may not understand. At St Peter's House, a person-centred approach is taken and behaviours are seen as a resident's attempt to communicate. Rather than take a pharmacological route-only used when all else has failed-the care home...

  • Agitation Therapy for Antisocial and Psychopathic Personalties: An Outline. Martens, Willem H.J. // American Journal of Psychotherapy;Spring2001, Vol. 55 Issue 2, p234 

    In this paper, a hypothetical model of agitation therapy for some categories of antisocial and psychopathic patients/offenders is presented. Agitation therapy is mainly meant for very problematic and aggressive individuals who do not (or hardly) respond (in some periods) to any other type of...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics